Barriers exist that can prevent minority and underserved populations from participating in cancer clinical trials. Social determinants can be useful for examining patient preferences and factors associated with treatment response and outcomes in order to effectively improve minority recruitment and retention into cancer clinical trials. Therefore, this study will collect data on social determinants of cancer treatment and outcomes to inform future interventions in cancer care delivery.
It is important to understand multiple personal-level factors that impact disease risks and outcomes to determine the most effective ways to establish precise medical strategies to prevent, diagnose, and treat chronic health conditions and diseases. This is especially important among minority and underserved populations that would benefit from more tailored healthcare approaches. This study will develop and assess strategies for circulating evidence about precision medicine and improving precision medicine approaches.